Tafamidis
Indications
- Treatment of transthyretin amyloidosis in patients with stage 1 symptomatic polyneuropathy (ATTR-PN) [using 20 mg capsules] (initiated under specialist supervision)
- Treatment of wild-type transthyretin amyloidosis in patients with cardiomyopathy (ATTR-CM) [using 61 mg capsules] (initiated under specialist supervision), Treatment of hereditary transthyretin amyloidosis in patients with cardiomyopathy (ATTR-CM) [using 61 mg capsules] (initiated under specialist supervision)
Drug Interactions
8 drug interactions identified for Tafamidis. Check the full interaction details, severity ratings, and clinical recommendations in the MedNext app.
Check Interactions in AppSafety Information
Side Effects
Common or very common Abdominal pain upper; diarrhoea; increased risk of infection Frequency not known Flatulence...
Full safety information, contraindications, and dosing available in the MedNext app.
Brand Names
Get the Full Monograph
Complete dosing, interactions, contraindications, side effects, and more for Tafamidis.
Download Free — 7-Day TrialNo credit card required
In the MedNext App
- Complete dosing regimens
- Full interaction details & severity
- AI-powered drug search
- All 2 brand names
- Dosing calculators
- CME/CPD tracking
- 40 language support
- Offline access
Source: MedNext Audited Proprietary Dataset
Last reviewed: 2026
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare professional before making clinical decisions. Verify all drug information with current clinical guidelines.
Access all 2866 drugs in the MedNext app
Complete monographs, AI-powered search, interaction checker, dosing calculators, and CME tracking — in 40 languages.
Download MedNext — Free 7-Day Trial